Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Receivables (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Receivables for 8 consecutive years, with $864.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables rose 5.21% to $864.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $864.2 million, a 5.21% increase, with the full-year FY2025 number at $864.2 million, up 5.21% from a year prior.
  • Receivables was $864.2 million for Q4 2025 at Select Medical Holdings, up from $825.8 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $1.1 billion in Q1 2024 to a low of $724.1 million in Q4 2023.
  • A 5-year average of $933.2 million and a median of $926.4 million in 2021 define the central range for Receivables.
  • Peak YoY movement for Receivables: rose 24.28% in 2021, then decreased 24.38% in 2023.
  • Select Medical Holdings' Receivables stood at $913.2 million in 2021, then increased by 4.86% to $957.6 million in 2022, then fell by 24.38% to $724.1 million in 2023, then grew by 13.43% to $821.4 million in 2024, then increased by 5.21% to $864.2 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Receivables are $864.2 million (Q4 2025), $825.8 million (Q3 2025), and $909.5 million (Q2 2025).